eli lilly retatrutide trial orforglipron oral GLP-1 phase 3 weight loss Eli Lilly and Company's Retatrutide

However, with the Medicare portion of the BALANCE Model on hold, CMS extended the Bridge until December 31, 2027

He has difficulty walking and is on blood thinners

Stomach Discomfort (Indigestion): Many patients report feelings of stomach discomfort or indigestion while on GLP-1 medications

Histamine Intolerance & the Microbiome Histamine intolerance is the term used to describe a range of symptoms attributed to excess histamine due to the inability to eliminate histamine

Phase 2 and phase 3 clinical trials for MASLD/MASH with GLP-1 receptor agonists and glucagon/GIP/GLP-1 receptor dual or triple agonists, using biopsy to assess hepatic endpoints, are summarised in Table 1